Welcome to Commercial Operations!
At Commercial Operations our mission is to bring innovative treatments to patients with neurodegenerative diseases.
We work every day to raise awareness about Alzheimer's Disease and with supporting and educating Health Care Professionals in the introduction of new therapeutic options.
We bring hope to patients, caregivers and Health Care Professionals in this new era for Alzheimer's Disease.
About BioArctic
BioArctic, founded in 2003, is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. BioArctic has a broad project portfolio of selective antibodies against various diseases of the central nervous system. Several of the projects utilize the company's proprietary BrainTransporter™, which is a technology that has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic has around 150 employees, is headquartered in Stockholm and BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap.
Already working at BioArctic?
Let’s recruit together and find your next colleague.